{"452331":{"#nid":"452331","#data":{"type":"news","title":"Professor Tony Kim Receives AHA Award to Further Research in Ending Heart Disease","body":[{"value":"\u003Cp\u003EYongTae \u201cTony\u201d Kim, faculty member of the Petit Institute for Bioengineering and Bioscience and the Institute for Electronics and Nanotechnology, recently received an American Heart Association (AHA) National Scientist Development Grant to help him combat the US\u0027s #1 killer, atherosclerosis.\u003C\/p\u003E\u003Cp class=\u0022p1\u0022\u003E\u201cAtherosclerosis is a time sensitive disease, and once you have it, it\u2019s hard to stop it,\u201d says Kim, assistant professor in the Woodruff School of Mechanical Engineering at the Georgia Institute of Technology. \u201cOur goal is to engineer a new nanometer scale material that can deliver genetic codes effectively to treat unhealthy blood cells in atherosclerotic plaques.\u201d\u003C\/p\u003E\u003Cp class=\u0022p1\u0022\u003EThe teams engineered delivery vehicles will combine a mimic of the natural HDL (high-density lipoprotein, or \u201cgood\u201d cholesterol) nanoparticles present in human blood and imaging agents to help view the paque build-up, as well as biological molecules to enable the target delivery of genetic material\u0026nbsp; to failing cells that will improve their function, alleviating the effects of atherosclerosis.\u003C\/p\u003E\u003Cp class=\u0022p1\u0022\u003E\u201cWe plan to determine if our engineered HDL vehicles provide an improved treatment option for atherosclerosis,\u201d says Kim, who plans to use cutting-edge microfluidic dynamics technology to synthesize the proposed nanocarriers, or vehicles, \u201cwhich is highly reproducible through the continuous synthesis process in microfluidics,\u201d he adds.\u003C\/p\u003E\u003Cp class=\u0022p1\u0022\u003E\u201cThis project will have several outcomes with the potential to impact treatment of cardiovascular disease,\u201d Kim says. For one thing, it will produce a new therapeutic platform capable of treating unhealthy blood vessel cells with minimal side effects. It also promotes the development of a novel, versatile platform for the study of microvasculature diseases.\u003C\/p\u003E\u003Cp class=\u0022p1\u0022\u003E\u201cThese new technologies will contribute to the development of a novel therapeutic and diagnostic paradigm for the study and treatment of atherosclerosis,\u201d says Kim, whose grant is for $308,000 over four years.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":"","field_summary_sentence":[{"value":"YongTae \u201cTony\u201d Kim, recently received an American Heart Association (AHA) Grant to help him combat US\u0027s #1 killer, atherosclerosis."}],"uid":"27863","created_gmt":"2015-09-25 13:57:00","changed_gmt":"2016-10-08 03:19:36","author":"Christa Ernst","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2015-09-25T00:00:00-04:00","iso_date":"2015-09-25T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1271","name":"NanoTECH"}],"categories":[{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"149","name":"Nanotechnology and Nanoscience"},{"id":"135","name":"Research"}],"keywords":[{"id":"7270","name":"atherosclerosis"},{"id":"3184","name":"cardiovascular disease"},{"id":"14219","name":"Coulter Department of Biomedical Engineering"},{"id":"12701","name":"Institute for Electronics and Nanotechnology"},{"id":"2194","name":"nanomedicine"},{"id":"84251","name":"YongTae \u201cTony\u201d Kim"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"},{"id":"39451","name":"Electronics and Nanotechnology"}],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":["christa.ernst@ien.gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}